Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk

NCT03113994 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
8
Enrollment
OTHER
Sponsor class

Stopped COVID-19 Pandemic

Conditions

Interventions

Sponsor

Dr. B. Catharine. Craven

Collaborators